ConductScience.org, home

Trial · NCT01631825

Results by group127

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Any AEs311participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Treatment-related AEs269participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962SAEs34participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Treatment-related SAEs6participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Severe AEs16participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Discontinuation due to AEs47participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Death1participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962AEs of special interest 17participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962AEs of special interest 24participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962AEs of special interest 354participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Valvular disease of the heart0participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Sitting systolic blood pressure, ≤ 100 mmHg9participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962QTcB ≥ 500 ms5participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962QTcF ≥ 500 ms2participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Application site reaction ≥ +++14participants
Incidence and Severity of Adverse Events (AEs), Vital Signs, and Laboratory ParametersSPM 962Weight decrease reported as AE8participants
Unified Parkinson's Disease Rating Scale (UPDRS) Part 3 Sum ScoreSPM 962Week 12-8.3Standard Deviation 7.1Scores on a scale
Unified Parkinson's Disease Rating Scale (UPDRS) Part 3 Sum ScoreSPM 962Week 24-8.0Standard Deviation 7.6Scores on a scale
Unified Parkinson's Disease Rating Scale (UPDRS) Part 3 Sum ScoreSPM 962Week 52-7.5Standard Deviation 8.6Scores on a scale
UPDRS Part 2 Sum Score (Average of on State and Off State)SPM 962Week 12-2.6Standard Deviation 3.0Scores on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01631825/results